S. Grootenboer‐Mignot

1.1k citations

25 papers · 599 indexed · h-index 14

Rheumatology top 2%
- Urticaria and Related Conditions 9
- Systemic Lupus Erythematosus Research 6
- Rheumatoid Arthritis Research and Therapies 4
Genetics top 10%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 5
Pathology and Forensic Medicine top 10%
- Autoimmune Bullous Skin Diseases 14
Periodontics top 10%
Dermatology top 10%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4
Pulmonary and Respiratory Medicine
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
Hematology
- Platelet Disorders and Treatments 2

Co-authors: Sylvie Chollet‐Martin P. Nicaise‐Roland Olivier Meyer Gilles Hayem Margarita Hurtado-Nédelec Raymond Ruimy Philippe Dieudé C. Prost‐Squarcioni
Cited by: Rheumatology Genetics Pathology and Forensic Medicine
Journals: American Journal of Respiratory and Critical Care Medicine (1 paper)The Lancet Oncology (1 paper)Frontiers in Immunology (3 papers)
Partner nations: France United States Norway

In The Last Decade

S. Grootenboer‐Mignot

23 papers receiving 587 citations

Peers

Countries citing papers authored by S. Grootenboer‐Mignot

Since Specialization

Citations

This map shows the geographic impact of S. Grootenboer‐Mignot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Grootenboer‐Mignot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Grootenboer‐Mignot more than expected).

Fields of papers citing papers by S. Grootenboer‐Mignot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Grootenboer‐Mignot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Grootenboer‐Mignot. The network helps show where S. Grootenboer‐Mignot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside S. Grootenboer‐Mignot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Grootenboer‐Mignot Line = papers co-authored together S. Grootenboer‐Mignot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Lichen planus pemphigoides with predominant mucous membrane involvement: a series of 12 patients and a literature review Frontiers in Immunology ·L. Combemale,G. Bohelay,Ishaï-Yaacov Sitbon,Btisseme Ahouach,M. Alexandre,Antoine Martin,Francis Pascal,I. Soued,Serge Doan,Florence Morin,S. Grootenboer‐Mignot,F. Caux,C. Prost‐Squarcioni,C. Le Roux‐Villet	2024	0
2	Erythema multiforme associated with anti‐plakin antibodies: a multicentric retrospective case series Journal of the European Academy of Dermatology and Venereology ·A. Weill,V. Descamps,François Chasset,T. Mahévas,Isabelle Bourgault‐Villada,P. Wolkenstein,Sylvie Chollet‐Martin,S. Oro,S. Grootenboer‐Mignot	2022	5
3	Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients Frontiers in Immunology ·G. Bohelay,M. Alexandre,C. Le Roux‐Villet,I. Sitbon,Serge Doan,I. Soued,Jason Shourick,Laurie Rousset,Benoît Mellottee,Michel Heller,N. Lièvre,C. Zumelzu,Florence Morin,S. Grootenboer‐Mignot,Éric Gabison,F. Caux,C. Prost‐Squarcioni,Philippe Musette	2022	9
4	Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients Frontiers in Immunology ·M. Alexandre,G. Bohelay,Thomas Gille,C. Le Roux‐Villet,I. Soued,Florence Morin,F. Caux,S. Grootenboer‐Mignot,C. Prost‐Squarcioni	2022	11
5	Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa Frontiers in Medicine ·Ahmad Yatim,G. Bohelay,S. Grootenboer‐Mignot,C. Prost‐Squarcioni,M. Alexandre,C. Le Roux‐Villet,Antoine Martin,E. Maubec,F. Caux	2019	19
6	Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases British Journal of Clinical Pharmacology ·B. Garel,(unknown),Daniele Afriat,C. Prost‐Squarcioni,F. Tétart,Benoît Bensaïd,Corina Bara Passot,M. Beylot‐Barry,V. Descamps,S. Duvert‐Lehembre,S. Grootenboer‐Mignot,G. Jeudy,A. Soria,Marie‐Blanche Valnet‐Rabier,A. Barbaud,F. Caux,Bénédicte Lebrun‐Vignes	2018	39
7	Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases Seminars in Arthritis and Rheumatism ·T. De Risi-Pugliese,F. Cohen Aubart,Julien Haroche,Philippe Moguelet,S. Grootenboer‐Mignot,Alexis Mathian,S. Oro,(unknown),Noémie Wendremaire,Françoise Aucouturier,F. Lepelletier,Makoto Miyara,Brigitte Bader‐Meunier,Philippe Rémy,Nicole Fabien,Camille Françès,Stéphane Barète,Zahir Amoura	2017	48
8	A polymorphous bullous dermatosis The Lancet Oncology ·Faustine Drahy,Claire Hotz,Nicolás Ortonne,L. Ghoufi,S. Grootenboer‐Mignot,Christophe Massard,Marie-Pierre Perrin,O. Chosidow,S. Oro	2017	0
9	Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults British Journal of Dermatology ·J. Gottlieb,S. Oro,M. Alexandre,S. Grootenboer‐Mignot,Françoise Aucouturier,É. Sbidian,Emmanuelle Tancrède‐Bohin,Pierre Schneider,Elodie Regnier,C. Picard‐Dahan,É. Bégon,C. Pauwels,K. Cury,Sophie Hüe,C. Bernardeschi,Nicolás Ortonne,F. Caux,P. Wolkenstein,O. Chosidow,C. Prost‐Squarcioni	2016	34
10	Rituximab, a new treatment for difficult‐to‐treat chronic erythema multiforme major? Five cases Journal of the European Academy of Dermatology and Venereology ·G. Hirsch,S. Oro,C. Fite,L. Valeyrie‐Allanore,Nicolás Ortonne,V. Buffard,Muriel Verlinde‐Carvalho,E. Marinho,J. Martinet,S. Grootenboer‐Mignot,V. Descamps,P. Wolkenstein,P. Joly,O. Chosidow	2015	10
11	Auto-anticorps des dermatoses bulleuses auto-immunes (pemphigus, pemphigoïde bulleuse) : ce que le dermatologue doit savoir Annales de Dermatologie et de Vénéréologie ·S. Oro,Sophie Hüe,S. Grootenboer‐Mignot,Claire André	2013	5
12	Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort Annals of the Rheumatic Diseases ·P. Nicaise‐Roland,Léonor Nogueira,Christophe Dematteï,Luc de Chaisemartin,Nathalie Rincheval,Martin Cornillet,S. Grootenboer‐Mignot,Philippe Dieudé,Maxime Dougados,Alain Cantagrel,Olivier Meyer,Guy Serre,Sylvie Chollet‐Martin	2013	36
13	Identification of Periplakin as a New Target for Autoreactivity in Idiopathic Pulmonary Fibrosis American Journal of Respiratory and Critical Care Medicine ·Camille Taillé,S. Grootenboer‐Mignot,Céline Boursier,Laurence Michel,Marie‐Pierre Debray,Jérôme Fagart,Lorena Barrientos,Arnaud Mailleux,Natacha Cigna,Florence Tubach,J. Marchal-Sommé,Paul Soler,Sylvie Chollet‐Martin,Bruno Crestani	2010	78
14	Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis Joint Bone Spine ·Alexandra Bruns,P. Nicaise‐Roland,Gilles Hayem,Élisabeth Palazzo,Philippe Dieudé,S. Grootenboer‐Mignot,Sylvie Chollet‐Martin,Olivier Meyer	2009	35
15	Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus Arthritis Research & Therapy ·Olivier Meyer,P. Nicaise‐Roland,Nolwenn Cadoudal,S. Grootenboer‐Mignot,Élisabeth Palazzo,Gilles Hayem,Philippe Dieudé,Sylvie Chollet‐Martin	2009	47
16	Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses British Journal of Dermatology ·S. Grootenboer‐Mignot,V. Descamps,C. Picard‐Dahan,P. Nicaise‐Roland,C. Prost‐Squarcioni,C. Leroux-Villet,C. Champagnat,A. Delaval,Françoise Aucouturier,B. Crickx,Sylvie Chollet‐Martin	2009	32
17	Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome Lara D. Veeken ·Margarita Hurtado-Nédelec,Sylvie Chollet‐Martin,P. Nicaise‐Roland,S. Grootenboer‐Mignot,Raymond Ruimy,Olivier Meyer,Gilles Hayem	2008	111
18	Second generation anti‐cyclic citrullinated peptide (anti‐CCP2) antibodies can replace other anti‐filaggrin antibodies and improve rheumatoid arthritis diagnosis Scandinavian Journal of Rheumatology ·S. Grootenboer‐Mignot,P. Nicaise‐Roland,Christophe Delaunay,Olivier Meyer,Sylvie Chollet‐Martin,C Labarre	2004	17
19	A second locus mapping to 2q35–36 for familial pseudohyperkalaemia European Journal of Human Genetics ·Massimo Carella,Pio D’Adamo,S. Grootenboer‐Mignot,Marie‐Christine Vantyghem,Laura Esposito,Angela D’Eustacchio,Romina Ficarella,Gordon W. Stewart,Paolo Gasparini,J. Delaunay,Achille Iolascon	2004	17
20	Sub‐lethal hydrops as a manifestation of dehydrated hereditary stomatocytosis in two consecutive pregnancies Prenatal Diagnosis ·S. Grootenboer‐Mignot,Aurore Crétien,Ingrid Laurendeau,Marie‐Hélène Poissonnier,V. Doireau,Y. Brossard,Gil Tchernia,Thérèse Cynober,J. Delaunay	2003	19

About S. Grootenboer‐Mignot

S. Grootenboer‐Mignot is a scholar working on Rheumatology, Pathology and Forensic Medicine and Genetics, having authored 25 papers that have together received 599 indexed citations. Recurring topics across this work include Autoimmune Bullous Skin Diseases (14 papers), Urticaria and Related Conditions (9 papers), Systemic Lupus Erythematosus Research (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Rheumatology (394 citations), Genetics (138 citations) and Pathology and Forensic Medicine (220 citations). S. Grootenboer‐Mignot has collaborated with scholars based in France, United States and Norway. Frequent co-authors include Sylvie Chollet‐Martin, P. Nicaise‐Roland, Olivier Meyer, Gilles Hayem, Margarita Hurtado-Nédelec, Raymond Ruimy, Philippe Dieudé, C. Prost‐Squarcioni, Élisabeth Palazzo and F. Caux. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, The Lancet Oncology and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact